BELLINI, Tiziana
 Distribuzione geografica
Continente #
NA - Nord America 15.610
AS - Asia 8.992
EU - Europa 5.376
SA - Sud America 1.328
Continente sconosciuto - Info sul continente non disponibili 349
AF - Africa 216
OC - Oceania 23
Totale 31.894
Nazione #
US - Stati Uniti d'America 15.234
SG - Singapore 3.285
CN - Cina 2.307
IT - Italia 1.276
BR - Brasile 1.025
VN - Vietnam 946
UA - Ucraina 805
DE - Germania 784
HK - Hong Kong 737
TR - Turchia 558
GB - Regno Unito 484
PL - Polonia 410
FI - Finlandia 369
FR - Francia 301
JP - Giappone 258
BD - Bangladesh 239
RU - Federazione Russa 238
SE - Svezia 238
CA - Canada 180
IN - India 168
MX - Messico 128
ID - Indonesia 113
AR - Argentina 107
NL - Olanda 90
ZA - Sudafrica 79
IQ - Iraq 60
BE - Belgio 53
ES - Italia 53
CO - Colombia 49
AT - Austria 43
EC - Ecuador 43
CZ - Repubblica Ceca 41
EE - Estonia 37
VE - Venezuela 35
PK - Pakistan 34
PH - Filippine 30
SA - Arabia Saudita 28
MY - Malesia 27
UZ - Uzbekistan 27
MA - Marocco 26
LT - Lituania 24
IR - Iran 22
CL - Cile 21
AE - Emirati Arabi Uniti 20
KR - Corea 20
JM - Giamaica 19
PY - Paraguay 18
TN - Tunisia 18
AU - Australia 17
ET - Etiopia 17
KE - Kenya 16
NP - Nepal 16
EG - Egitto 15
BG - Bulgaria 14
DZ - Algeria 14
IE - Irlanda 14
AZ - Azerbaigian 12
RO - Romania 12
UY - Uruguay 12
PE - Perù 11
CH - Svizzera 10
JO - Giordania 10
AL - Albania 9
EU - Europa 9
IL - Israele 9
PT - Portogallo 9
SD - Sudan 9
CR - Costa Rica 8
KZ - Kazakistan 8
AO - Angola 7
BO - Bolivia 7
BY - Bielorussia 7
LB - Libano 7
NI - Nicaragua 7
OM - Oman 7
RS - Serbia 7
TT - Trinidad e Tobago 7
DK - Danimarca 6
HN - Honduras 6
LV - Lettonia 6
PS - Palestinian Territory 6
TW - Taiwan 6
GE - Georgia 5
GR - Grecia 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
A2 - ???statistics.table.value.countryCode.A2??? 4
HU - Ungheria 4
KW - Kuwait 4
PA - Panama 4
TH - Thailandia 4
BB - Barbados 3
DJ - Gibuti 3
GD - Grenada 3
HR - Croazia 3
KG - Kirghizistan 3
QA - Qatar 3
ZW - Zimbabwe 3
Totale 31.515
Città #
Singapore 2.110
Ashburn 1.568
San Jose 1.185
Woodbridge 1.185
Fairfield 987
Chandler 927
Jacksonville 885
Beijing 735
Santa Clara 730
Hong Kong 719
Houston 719
Ann Arbor 684
Wilmington 412
Warsaw 391
Seattle 362
Dallas 334
Izmir 312
Cambridge 299
Ho Chi Minh City 291
Council Bluffs 275
Nanjing 255
Tokyo 248
Los Angeles 244
Ferrara 241
Hanoi 217
Princeton 207
New York 202
Munich 185
Boardman 171
Lauterbourg 170
Milan 153
Helsinki 127
Dearborn 123
Nanchang 95
São Paulo 91
Shanghai 88
Shenyang 87
Mexico City 81
San Diego 77
Addison 74
Buffalo 71
Toronto 69
London 68
Tianjin 67
Changsha 66
Turku 66
Bologna 65
Jakarta 65
Orem 64
Rome 58
Chennai 54
Hebei 52
Chicago 51
Bremen 50
Da Nang 50
Montreal 50
Phoenix 50
Brooklyn 48
Brussels 47
Hefei 46
Jiaxing 46
Frankfurt am Main 42
Moscow 41
San Francisco 41
Haiphong 38
Johannesburg 37
Jinan 36
Denver 35
Brno 33
Norwalk 33
Stockholm 33
The Dalles 33
Boston 32
Orange 32
Poplar 32
Ningbo 31
Vienna 31
Atlanta 29
Manchester 29
Guangzhou 28
Rio de Janeiro 28
Curitiba 27
Redwood City 25
Hải Dương 23
Kunming 22
Tashkent 22
Amsterdam 21
Ankara 21
Augusta 21
Baghdad 21
Charlotte 21
Mountain View 21
Auburn Hills 20
Belo Horizonte 20
Leawood 20
Brasília 19
Zhengzhou 19
Düsseldorf 18
Naples 18
San Mateo 18
Totale 20.520
Nome #
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 418
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study 330
Decreased Arylesterase activity of Paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 305
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 279
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 254
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 254
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 254
Chimica Medica e propedeutica Biochimica 252
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 252
Leishmania Infantum Cryptic Infection in Immunosuppressed Rheumatologic Patients and Healthy Controls from Northern Italy: Epidemiological Variables That Can Affect Infection Risk 250
Transfusion of stored red blood cells in critically ill trauma patients: a retrospective study 247
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 245
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 241
Evaluation of a possible role of oxidative stress in climacteric symptoms. 234
Antiprotozoal activity of 6-aminonicotinamide against Leishmania infantum promastigotes 234
Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals 230
A rapid method for purification of myelin basic protein 229
Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs 225
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 222
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 218
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 218
A Comparison Between Different Anti-Retroviral Therapy Regimes on Soluble Inflammation Markers: a Pilot Study 213
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 210
A machine-learning based bio-psycho-social model for the prediction of non-obstructive and obstructive coronary artery disease 209
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 208
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 205
Activation of the Sendai virus fusion protein by receptor binding 205
A Real-Time PCR to Detect Leishmania Infantum DNA in Immunocompetent Patients with Chronic Inflammatory Rheumatisms Living in Rural Areas of Northern Italy and Treated with Biologic Drugs. 205
Affinity labelling of the NADP+-binding site of glucose 6-phosphate dehydrogenase from Candida utilis 204
Activation of the sendai virus fusion protein by receptor binding 203
HUMAN ASYMPTOMATIC LEISHMANIA INFANTUM INFECTION. NEW INSIGHTS IN PATIENTS WITH CHRONIC RHEUMATIC DISEASES TREATED WITH BIOLOGICAL AGENTS AND LIVING IN RURAL AREAS OF NORTHERN ITALY 203
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 199
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 199
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 198
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 196
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 196
Le Metalloproteasi come potenziali marcatori biologici nella Sclerosi Multipla 194
Arylesterase activity of paraoxonase-1 in serum and cerebrospinal fluid of patients with alzheimer’s disease and vascular dementia 194
Characterization of PAR-mediated signaling induced by activated coagulation factor X mutants 193
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 193
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 193
Long-term expression of highly differentiated functions by isolated porcine hepatocytes perfused in a radial-flow bioreactor 192
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 192
Mutual communication of envelope glycoproteins of paramixoviruses 191
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 191
Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: Role of MPO specific activity in coronary artery disease 191
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 188
Le beta-esosaminidasi liquorali in sogetti affetti da sclerosi multipla e in controlli sani 187
Analisi della proteina basica della mielina nel liquor 187
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 186
Finding peculiar patterns of kinetoplastida enzymes to be exploited in drug design 186
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 185
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study 184
Characterization of anti-coagulant properties of prenylated coumarin ferulenol. 183
Sex difference impacts on the relationship between paraoxonase-1 (Pon1) and type 2 diabetes 183
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 180
Testosterone-to-estradiol ratio and platelet thromboxane release in ischemic heart disease: the EVA project 179
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 178
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 178
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 176
Biochemical study in adult population with stroke in Ferrara, Fabry disease 173
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 172
A Calcium- and GTP-Dependent Transglutaminase in Leishmania infantum 171
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 171
Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1 170
A catalytic tyrosine at the active site of sendai virus neuraminidase 169
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 168
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 167
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 167
Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot study. 166
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 164
Anomeric specificity of the neuraminidase from sendai virus 164
null 163
Pain in head and neck cancer patients: The role of gender 163
Substrate-induced intramolecular proton transfer in 6-phosphogluconate dehydrogenase from Candida utilis 161
Inhibition of Sendai virus hemagglutinin neuraminidase by the fusion protein 160
Non-enzymic protein phosphorylation. Phosphorylation of 6-phosphogluconate dehydrogenase by acyl phosphates 160
Evidence for multiple pairs of vicinal thiols in some proteins 159
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 158
Mild proteolysis induces a ready-to-fuse state on Sendai virus envelope 157
The stabilization by a coenzyme analog of a conformational change induced by substrate in 6-phosphogluconate dehydrogenase 156
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 156
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 156
Elevato riscontro di DNA circolante di Leishmania infantum in soggetti immunocompetenti affetti da malattie reumatologiche e trattati con farmaci biotecnologici. 156
6-fosfogluconato deidrogenasi da eritrociti umani: interazione con i coenzimi 155
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 155
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 153
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 153
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 153
Differential pathogenicity and lethality of bubonic plague (1720–1945) by sex, age and place 152
Brain and serum cholesterol metabolism during perimenopausal transition: a risk factor for Alzheimer’s disease? 152
Circulating Skeletal Troponin During Weaning From Mechanical Ventilation and Their Association to Diaphragmatic Function: A Pilot Study 152
Sex Differences in Albumin Quotient and Cerebrospinal Fluid Total Protein Content Do Not Depend on Anthropometric Factors 150
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 150
Rilevanza delle forme attive delle gelatinasi nel monitoraggio dell'attività della Sclerosi multipla 149
Gender differences in audio-vestibular disorders 148
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 146
Gelatinase: enzymatic activity as potential biomarker in multiple sclerosis 146
Myelin basic protein inhibits the calcium response to phytohaemagglutinin in human lymphocytes 145
The effect of inorganic phosphate on the stability of some enzymes 145
Totale 19.259
Categoria #
all - tutte 146.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 854
Totale 147.679


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.715 0 175 70 62 90 101 51 92 65 183 179 647
2022/20232.132 230 161 54 264 358 297 88 201 244 33 126 76
2023/2024952 98 121 62 25 95 89 25 66 30 23 28 290
2024/20254.210 119 78 375 164 528 329 142 246 650 565 564 450
2025/202612.269 1.119 552 1.168 1.547 1.634 781 1.458 660 1.147 1.329 540 334
2026/2027676 332 344 0 0 0 0 0 0 0 0 0 0
Totale 31.894